Turmeric may help develop effective anti-cancer drug

Credit: Prchi Palwe/ Unsplash

Curcumin, a polyphenol extracted from Curcuma longa, also known as turmeric, has gained attention from scientists worldwide for its biological properties as an antioxidant, anti-inflammatory, antimicrobial, and antiviral agent.

In addition, curcumin’s anticancer potential has been the most described and still remains under investigation.

In a recent review study at Temple University and elsewhere, researchers discussed the most significant research findings.

Previously, many scientists have discussed the real health benefits of Curcumin, often stimulating very passionate debate.

As scientists involved in studies related to natural compounds and cancer, the team wanted to explore the most recent findings on this topic.

The review has collected studies concerning the anticancer potential of curcumin against the most widespread cancers and also describes the molecular mechanisms of action.

Moreover, the problem of the bioavailability of curcumin, as well as the most recent advances in the clinical use of curcumin and new drug formulations, are discussed.

The researchers conclude that thanks to its effects on different signaling pathways and molecular targets involved in the development of several cancers, curcumin represents a promising candidate as an effective anticancer drug, either alone or in combination with other treatments.

If you care about cancer, please read studies about why aspirin can prevent colon cancer, and this vegetable oil increase spread of cancer.

For more information about nutrition, please see recent studies about 10 easy tips for reducing sodium in your diet, and results showing antioxidants could help reduce the dementia risk.

The study was published in Nutrients and conducted by Antonio Giordano et al.

Copyright © 2022 Knowridge Science Report. All rights reserved.